X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3831) 3831
Publication (542) 542
Book Review (120) 120
Book Chapter (58) 58
Newspaper Article (29) 29
Conference Proceeding (16) 16
Book / eBook (14) 14
Magazine Article (7) 7
Dissertation (4) 4
Transcript (4) 4
Newsletter (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2229) 2229
animals (1793) 1793
index medicus (1783) 1783
male (1739) 1739
dopamine (1617) 1617
neurosciences (1496) 1496
pharmacology & pharmacy (1154) 1154
female (1055) 1055
rats (894) 894
psychiatry (870) 870
adult (665) 665
dopamine - metabolism (628) 628
serotonin (525) 525
cocaine (521) 521
clinical neurology (518) 518
parkinson's disease (490) 490
dopamine uptake inhibitors - adverse effects (470) 470
middle aged (466) 466
dose-response relationship, drug (449) 449
brain (421) 421
mice (409) 409
rats, sprague-dawley (377) 377
article (374) 374
treatment outcome (336) 336
double-blind (333) 333
dopamine uptake inhibitors - therapeutic use (332) 332
neurology (320) 320
disease models, animal (319) 319
brain - drug effects (318) 318
dopamine uptake inhibitors - pharmacology (304) 304
analysis (289) 289
brain - metabolism (285) 285
research (281) 281
time factors (279) 279
parkinsons-disease (277) 277
nucleus-accumbens (276) 276
cocaine - adverse effects (264) 264
drug therapy (259) 259
neurons (251) 251
antidepressants (246) 246
motor activity - drug effects (246) 246
bupropion - therapeutic use (245) 245
dopamine uptake inhibitors - administration & dosage (242) 242
schizophrenia (236) 236
dopamine transporter (234) 234
adolescent (228) 228
depression (227) 227
phenols (227) 227
health aspects (226) 226
parkinson disease - drug therapy (226) 226
aged (225) 225
amphetamine (218) 218
rodents (216) 216
double-blind method (212) 212
serotonin - metabolism (210) 210
care and treatment (208) 208
cocaine - pharmacology (207) 207
bupropion (205) 205
pharmacology/toxicology (205) 205
behavior, animal - drug effects (203) 203
drugs (200) 200
biomedicine (197) 197
pharmacotherapy (195) 195
addiction (194) 194
substance abuse (193) 193
norepinephrine (192) 192
pharmacology (192) 192
rats, wistar (190) 190
prefrontal cortex (188) 188
biochemistry & molecular biology (185) 185
dopamine receptors (185) 185
physiological aspects (185) 185
toxicology (184) 184
serotonin uptake inhibitors - therapeutic use (182) 182
drug abuse (174) 174
rat (173) 173
serotonin uptake inhibitors - adverse effects (173) 173
corpus striatum - metabolism (171) 171
oxidative stress (171) 171
drug interactions (168) 168
medicine & public health (167) 167
methylphenidate (167) 167
risk factors (166) 166
receptors (164) 164
analysis of variance (163) 163
in-vivo (163) 163
bupropion - adverse effects (157) 157
neurotoxicity (157) 157
behavioral sciences (154) 154
smoking cessation (154) 154
corpus striatum - drug effects (153) 153
mental disorders (153) 153
pregnancy (153) 153
reward (153) 153
neurons - drug effects (152) 152
cocaine - administration & dosage (150) 150
smoking cessation - methods (149) 149
levodopa (144) 144
methamphetamine (144) 144
striatum (143) 143
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3860) 3860
French (15) 15
Spanish (13) 13
Japanese (7) 7
German (6) 6
Polish (6) 6
Dutch (5) 5
Swedish (3) 3
Hungarian (2) 2
Norwegian (2) 2
Italian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2006, Volume 354, Issue 12, pp. 1243 - 1252
Journal Article
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 2006, Volume 110, Issue 2, pp. 135 - 370
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a high social cost. Depressed patients generally display... 
Antidepressant | SSRI | Multi-target | Network theory | Mood | Depression | Co-morbidity | METABOTROPIC GLUTAMATE-RECEPTOR | co-morbidity | mood | antidepressant | network theory | PROTEIN-COUPLED RECEPTORS | FORCED SWIMMING TEST | SEROTONIN REUPTAKE INHIBITORS | TREATMENT-RESISTANT-DEPRESSION | FREELY-MOVING RATS | CORTICOTROPIN-RELEASING-FACTOR | TRANSCRANIAL MAGNETIC STIMULATION | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | depression | multi-target | METHYL-D-ASPARTATE | Depressive Disorder, Major - etiology | Cyclohexanols - adverse effects | Dopamine Uptake Inhibitors - adverse effects | Depressive Disorder, Major - metabolism | Humans | Dopamine Uptake Inhibitors - therapeutic use | Nerve Net - drug effects | Drug Delivery Systems | Brain - metabolism | Drug Design | Neurons - metabolism | Drug Therapy, Combination | Neurons - drug effects | Dopamine - metabolism | Morpholines - adverse effects | Morpholines - therapeutic use | Bupropion - therapeutic use | Depressive Disorder, Major - drug therapy | Adrenergic Uptake Inhibitors - adverse effects | Antidepressive Agents - classification | Adrenergic Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Antidepressive Agents - therapeutic use | Brain - drug effects | Venlafaxine Hydrochloride | Animals | Norepinephrine - metabolism | Serotonin - metabolism | Nerve Net - metabolism | Cyclohexanols - therapeutic use | Bupropion - pharmacology | Antidepressive Agents - adverse effects | Nitrogen oxide | Drugs | Neuropeptide Y | Care and treatment | Monoamine oxidase | Corticosteroids | Neurons | Glycogen | Depression, Mental | Development and progression | Serotonin uptake inhibitors | Peptide hormones | Methyl aspartate | Synthesis | Workplace multiculturalism | GABA | Drug therapy, Combination | Health aspects | Noradrenaline
Journal Article